Frontiers in Immunology (Oct 2022)
Corrigendum: Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation
- Hongfeng Huang,
- Hongfeng Huang,
- Hongfeng Huang,
- Qixia Shen,
- Qixia Shen,
- Qixia Shen,
- Jingyi Zhou,
- Jingyi Zhou,
- Jingyi Zhou,
- Xiuyan Yang,
- Xiuyan Yang,
- Xiuyan Yang,
- Qiuqin Cai,
- Qiuqin Cai,
- Qiuqin Cai,
- Jia Shen,
- Jia Shen,
- Jia Shen,
- Shi Feng,
- Shi Feng,
- Shi Feng,
- Wenqing Xie,
- Wenqing Xie,
- Hong Jiang,
- Hong Jiang,
- Hong Jiang,
- Jianghua Chen,
- Jianghua Chen,
- Jianghua Chen
Affiliations
- Hongfeng Huang
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Hongfeng Huang
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Hongfeng Huang
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Qixia Shen
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Qixia Shen
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Qixia Shen
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Jingyi Zhou
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Jingyi Zhou
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Jingyi Zhou
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Xiuyan Yang
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Xiuyan Yang
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Xiuyan Yang
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Qiuqin Cai
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Qiuqin Cai
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Qiuqin Cai
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Jia Shen
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Jia Shen
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Jia Shen
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Shi Feng
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Shi Feng
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Shi Feng
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Wenqing Xie
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Wenqing Xie
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Hong Jiang
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Hong Jiang
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Hong Jiang
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- Jianghua Chen
- Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- Jianghua Chen
- Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- Jianghua Chen
- Institute of Nephropathy, Zhejiang University, Hangzhou, China
- DOI
- https://doi.org/10.3389/fimmu.2022.1052676
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- hematopoietic stem cell infusion
- immune tolerance
- immunosuppression withdrawal
- chimerism
- GVHD
- kidney transplantation